Metagenomi Therapeutics Ownership & Insider Activity

Metagenomi Therapeutics (MGX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 11.8% of shares outstanding. Institutional investors hold 7.2%. Over the past 90 days, insiders made 1 purchase worth $23K and 3 sales worth $5K.

Shares Outstanding

37.777M

Shares Float

30.637M

Insider Shares Owned

4.455M

Insider % Owned

11.8%

Institutional Shares Held

2.732M

Institutional % Held

7.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$23K total

Sales (90d)

$5K total

Net Activity

Net Buying

Net Value (90d)

$18K

Metagenomi Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 9, 2026	Laurence Reid	—	BUY	20.000K	$1.17	$23K
Sep 8, 2026	Matthew Wein	SEE REMARKS	SELL	358.000	$1.16	$415
Sep 8, 2026	Jian Irish	SEE REMARKS	SELL	2.140K	$1.16	$2K
Sep 8, 2026	Pamela Wapnick	CHIEF FINANCIAL OFFICER	SELL	1.911K	$1.16	$2K
Jun 5, 2026	Pamela Wapnick	CHIEF FINANCIAL OFFICER	SELL	2.884K	$1.30	$4K
Jun 5, 2026	Jian Irish	SEE REMARKS	SELL	3.737K	$1.30	$5K
Jun 5, 2026	Matthew Wein	SEE REMARKS	SELL	558.000	$1.30	$725

Metagenomi Therapeutics Inc

Metagenomi Therapeutics Ownership & Insider Activity

Metagenomi Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch